Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1306 AL 1320

[Genetic factors associated with dementia in Parkinson's disease (PD)]

Romo-Gutiérrez D, Yescas P, López-López M, Boll MC.

Gac Med Mex. 2015 Jan-Feb;151(1):110-8.

A heme oxygenase-1 transducer model of degenerative and developmental brain disorders

Schipper HM, Song W.

Int J Mol Sci. 2015 Mar 9;16(3):5400-19. doi: 10.3390/ijms16035400.

On visual hallucinations and cortical networks: a trans-diagnostic review

Carter R, Ffytche DH.

J Neurol. 2015 Jul;262(7):1780-90. doi: 10.1007/s00415-015-7687-6. Epub 2015 Mar 13.

[New therapeutic approaches]

Kurz A, Grimmer T.

Ther Umsch. 2015 Apr;72(4):279-85. doi: 10.1024/0040-5930/a000676.

[Mental time dysfunction in Parkinson's and Alzheimer's diseases]

Honma M, Kuroda T, Futamura A, Sugimoto A, Kawamura M.

Brain Nerve. 2015 Mar;67(3):297-302. doi: 10.11477/mf.1416200135.

[Differential diagnosis of dementia with lewy bodies]

Orimo S.

Brain Nerve. 2015 Apr;67(4):413-25. doi: 10.11477/mf.1416200157.

Use of CSF α-synuclein in the differential diagnosis between Alzheimer's disease and other neurodegenerative disorders

Wang ZY, Han ZM, Liu QF, Tang W, Ye K, Yao YY.

Int Psychogeriatr. 2015 Sep;27(9):1429-38. doi: 10.1017/S1041610215000447. Epub 2015 Apr 8.

Visuo-constructional functions in patients with mild cognitive impairment, Alzheimer's disease, and Parkinson's disease

Lehrner J, Krakhofer H, Lamm C, Macher S, Moser D, Klug S, Dal-Bianco P, Pirker W, Auff E, Pusswald G.

Neuropsychiatr. 2015;29(3):112-9. doi: 10.1007/s40211-015-0141-2. Epub 2015 Apr 11.

Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review

Petrou M, Dwamena BA, Foerster BR, MacEachern MP, Bohnen NI, Müller ML, Albin RL, Frey KA.

Mov Disord. 2015 Jun;30(7):928-35. doi: 10.1002/mds.26191. Epub 2015 Apr 16.

PARP-1 involvement in neurodegeneration: A focus on Alzheimer's and Parkinson's diseases

Martire S, Mosca L, d'Erme M.

Mech Ageing Dev. 2015 Mar;146-148:53-64. doi: 10.1016/j.mad.2015.04.001. Epub 2015 Apr 13.

PET imaging in neurology: Alzheimer's and Parkinson's diseases

Sarikaya I.

Nucl Med Commun. 2015 Aug;36(8):775-81. doi: 10.1097/MNM.0000000000000320.

The role of TREM2 R47H as a risk factor for Alzheimer's disease, frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and Parkinson's disease

Lill CM, Rengmark A, Pihlstrøm L, Fogh I, Shatunov A, Sleiman PM, Wang LS, Liu T, Lassen CF, Meissner E, Alexopoulos P, Calvo A, Chio A, Dizdar N, Faltraco F, Forsgren L, Kirchheiner J, Kurz A, Larsen JP, Liebsch M, Linder J, Morrison KE, Nissbrandt H, Otto M, Pahnke J, Partch A, Restagno G, Rujescu D, Schnack C, Shaw CE, Shaw PJ, Tumani H, Tysnes OB, Valladares O, Silani V, van den Berg LH, van Rheenen W, Veldink JH, Lindenberger U, Steinhagen-Thiessen E; SLAGEN Consortium; Teipel S, Perneczky R, Hakonarson H, Hampel H, von Arnim CAF, Olsen JH, Van Deerlin VM, Al-Chalabi A, Toft M, Ritz B, Bertram L.

Alzheimers Dement. 2015 Dec;11(12):1407-1416. doi: 10.1016/j.jalz.2014.12.009. Epub 2015 Apr 30.

Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases

Montine TJ, Montine KS.

J Exp Med. 2015 May 4;212(5):601-5. doi: 10.1084/jem.20150656.

Ferulic acid and Alzheimer's disease: promises and pitfalls

Nabavi SF, Devi KP, Malar DS, Sureda A, Daglia M, Nabavi SM.

Mini Rev Med Chem. 2015;15(9):776-88. doi: 10.2174/1389557515666150522102545.

Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias

Bronner G, Aharon-Peretz J, Hassin-Baer S.

Handb Clin Neurol. 2015;130:297-323. doi: 10.1016/B978-0-444-63247-0.00017-1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias